Hong Kong stock market anomaly | Zhongyang Pharmaceutical (06127.HK) rose more than 4%, with a net profit attributable to the mother of HK$80.7061 million in the first three quarters.
According to the Securities Times app, Zhao Yan's new drug (06127.HK) rose over 4%, up 4.34% to HK$21.66 as of the time of publication, with a turnover of 2.09 billion HK dollars.
Latest
